Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya.

Similar presentations


Presentation on theme: "Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya."— Presentation transcript:

1 Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya B. Reddy, M.D., Larry Kluskens, M.D., Darius Francescatti, M.D., Kambiz Dowlat,M.D., Popi Sizipikou, M.D., Paolo Gattuso, M.D.

2 I. Introduction Fine-needle aspiration (FNA) cytology by Martin and Ellis - diagnosis of palpable breast mass - sensitive - specific - economical - safe - part of diagnostic triad: - clinical breast exam - mammography

3 II. Objectives Study and compare the accuracy of FNA performed in women with breast tumors who were younger and older than 40 years. To determine whether the patient’s age was pertinent while interpreting a FNA.

4 III. Methodology Patients: retrospective search of 1,158 FNA biopsies for clinically palpable breast mass at Rush Presbyterian St. Luke’s Medical center and Loyola University Medical Center between 1982 and 2000. Group 1: 231 women younger than 40 Group 2: 927 women 41 and older

5 III. Methodology Histopathologic diagnoses, based on needle core biopsy, excisional biopsy or mastectomy FNA’s by pathologists: 23-gauge needle, 10mL syringe mounted on an aspiration device. Smears fixed in alcohol Stained with papanicolaou stain Smears were air dried Stained with the Diff-quick method for immediate evaluation

6

7

8 III. Methodology Malignant – presence of cancerous cells
Benign – absence of cancerous cells Suspicious – suggestive cytologic features but did not completely fulfill the criteria of being malignant - Cytologic material not fixed well

9 III. Methodology Sensitivity, specificity, positive predictive value, negative predictive value, false negative rate and false positive rate were calculated for group 1, group 2, and the entire cohort.

10 IV. Results Group 1 Group 2 40 years and younger 231/ 1,158 patients
41 years and older 927/ 1,158 patients

11 Group 1: FNA Diagnosis Malignant Diagnosis Benign Diagnosis
117 patients 1 false positive (atypical papillomatosis) positive predictive value = 99% Benign Diagnosis 91 patients 1 false negative (infiltrating ductal carcinoma) negative predictive value = 99%

12 Group 1: FNA Diagnosis Suspicious Diagnosis Histopathology 20 patients
10 malignant 10 benign

13 Group 1: FNA Diagnosis Overall sensitivity 99% Overall specificity

14 Group 2: FNA Diagnosis Malignant Diagnosis 693 patients
3 false positives (2 atypical ductal hyperplasia & 1 atypical papilloma) positive predictive value = 99% Benign Diagnosis 131 patients 18 false negatives (13 infiltrating ductal carcinoma, 4 infiltrating lobular carcinoma & 1 ductal carcinoma in-situ) negative predictive value = 86%

15 Group 2: FNA Diagnosis Suspicious Diagnosis Histopathology 90 patients
68 malignant 22 benign

16 Group 2: FNA Diagnosis Overall sensitivity 98% Overall specificity 97%

17 V. Summary

18 VI. Appraisal The objectives of the study are clearly stated.
The study design is suitable for the objectives. The subjects used were the right sample to answer the objectives. The study is large enough to achieve its objectives. All subjects were accounted. The results are presented clearly, objectively and in sufficient detail to enable readers to make their own judgment. The author's conclusions are justified by the data. The results of the study can be applied locally.


Download ppt "Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya."

Similar presentations


Ads by Google